These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 4930209)

  • 1. Immunization with irradiated tumour cells and specific lymphocyte cytotoxicity in malignant melanoma.
    Currie GA; Lejeune F; Fairley GH
    Br Med J; 1971 May; 2(5757):305-10. PubMed ID: 4930209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmunization with irradiated tumour cells in human malignant melanoma.
    Ikonopisov RL; Lewis MG; Hunter-Craig ID; Bodenham DC; Phillips TM; Cooling CI; Proctor J; Fairley GH; Alexander P
    Br Med J; 1970 Jun; 2(5712):752-4. PubMed ID: 4913783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum mediated inhibition of the immunological reactions of the patient to his own tumour: a possible role for circulating antigen.
    Currie GA; Basham C
    Br J Cancer; 1972 Dec; 26(6):427-38. PubMed ID: 4119105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of autoimmunization with irradiated tumour cells on specific cell-mediated immunity in patients with malignant melanoma.
    Currie GA
    Proc R Soc Med; 1972 Feb; 65(2):144-7. PubMed ID: 4563684
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytotoxicity responses to melanoma cells by human lymphoid cell subpopulations.
    O'Neill PA; Mackler BF; Romsdahl MM
    J Natl Cancer Inst; 1976 Aug; 57(2):431-4. PubMed ID: 1087348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxicity reactions during immunotherapy of melanoma with neuraminidase altered autologous tumor cells.
    Miller EE; Rosato FE; Brown AS; Moskovitz A; Johnson J
    J Surg Oncol; 1976; 8(1):31-4. PubMed ID: 1249939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonspecific lymphocyte cytotoxicity in patients with malignant melanoma, renal cell carcinoma, and sarcomas, and in nontumor patients.
    Bukowski RM; Barna B; Deodhar SD; Hewlett JS
    Cancer; 1976 Nov; 38(5):1962-7. PubMed ID: 991109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of active immunization with irradiated tumour cells on specific serum inhibitors of cell-mediated immunity in patients with disseminated cancer.
    Currie GA
    Br J Cancer; 1973 Jul; 28(1):25-35. PubMed ID: 4724610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour-specific antibodies in human malignant melanoma and their relationship to the extent of the disease.
    Lewis MG; Ikonopisov RL; Nairn RC; Phillips TM; Fairley GH; Bodenham DC; Alexander P
    Br Med J; 1969 Sep; 3(5670):547-52. PubMed ID: 4896110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic antibodies to cultured melanoma cells in the sera of melanoma patients.
    Ferrone S; Pellegrino MA
    J Natl Cancer Inst; 1977 May; 58(5):1201-4. PubMed ID: 67208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte anergy in patients with carcinoma.
    Nind AP; Nairn RC; Rolland JM; Guli EP; Hughes ES
    Br J Cancer; 1973 Aug; 28(2):108-17. PubMed ID: 4581078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte cytotoxicity against autologous tumour biopsy cells in humans.
    Vose BM; Vanky F; Klein E
    Int J Cancer; 1977 Oct; 20(4):512-9. PubMed ID: 914394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxicity of lymphocytes from healthy subjects and from melanoma patients against cultured melanoma cells.
    Pavie-Fischer J; Kourilsky FM; Picard F; Banzet P; Puissant A
    Clin Exp Immunol; 1975 Sep; 21(3):430-41. PubMed ID: 1204255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour-associated lymphocyte cytotoxicity superimposed on "spontaneous" cytotoxicity in melanoma patients.
    de Vries JE; Rümke P
    Int J Cancer; 1976 Feb; 17(2):182-90. PubMed ID: 942943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human tumor cells grown in fetal calf serum and human serum: influences on the tests for lymphocyte cytotoxicity, serum blocking and serum arming effects.
    Sulit HL; Golub SH; Irie RF; Gupta RK; Grooms GA; Morton DL
    Int J Cancer; 1976 Apr; 17(4):461-8. PubMed ID: 945229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in distribution of human malignant melanoma membrane antigens in the presence of human antibody by immunofluorescence.
    Leong SP; Sutherland CM; Krementz ET
    Cancer Res; 1977 Jan; 37(1):293-8. PubMed ID: 318607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous and antibody-dependent cellular cytotoxicity in melanoma patients and healthy control presons.
    Peter HH; Knoop F; Kalden JR
    Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(3):263-81. PubMed ID: 134545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential in vitro reactivity of lymphocytes from melanoma patients receiving immunotherapy compared with the reactivity of lymphocytes from healthy donors.
    Berkelhammer J; Mastrangelo MJ; Laucius JF; Bodurtha AJ; Prehn RT
    Int J Cancer; 1975 Oct; 16(4):571-8. PubMed ID: 51835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour-associated antigens and tumour-host interactions.
    Baldwin RW
    Proc R Soc Med; 1971 Oct; 64(10):1039-42. PubMed ID: 4335921
    [No Abstract]   [Full Text] [Related]  

  • 20. Early onset of serum blocking in a murine melanoma model.
    Bray AE; Holt PG; Roberts LM; Keast D
    Int J Cancer; 1975 Oct; 16(4):607-15. PubMed ID: 1176208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.